Home Categories AtrialNatriureticPeptide(ANP)(1-28),rat(Atrialnatriureticfactor(1-28)(rat))
M8012247

AtrialNatriureticPeptide(ANP)(1-28),rat(Atrialnatriureticfactor(1-28)(rat)) , 98% , 88898-17-3

Synonym(s):
α-Atriopeptin, rat;α-rANP;ANF (123-150), rat;ANF 1-28;rANP

CAS NO.:88898-17-3

Empirical Formula: C128H205N45O39S2

Molecular Weight: 3062.41

MDL number: MFCD00076228

Pack Size Price Stock Quantity
1mg RMB3908.00 In Stock
others     Enquire
Update time: 2022-07-08

PRODUCT Properties

Density  1.54±0.1 g/cm3(Predicted)
storage temp.  -20°C
solubility  0.05 M acetic acid: 1 mg/mL, clear, colorless
form  Solid
color  White to off-white
Water Solubility  Soluble to 1 mg/ml in water
Sequence H-Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr-OH(Disulfide bridge: Cys7-Cys23)

Description and Uses

Atrial natriuretic peptide is the first cardiac hormone isolated from the atria with potent hypotensive and natriuretic/diuretic actions. It is a drug target for hypertension and cardiac/renal failure. The presence of a natriuretic factor in the rat heart was first reported in 1981; it was isolated in 1983 from the rat and human atria.

Atrial Natriuretic Peptide rat has been used:

  • In the absorption test to confirm the specificity of the anti-NP antibodies.
  • To study the effects of atrial natriuretic peptide (ANP) on renal water and sodium regulation in rats.
  • To study the integrated biological effects of ANP on myocardial infarction using mice models.

Safety

Safety Statements  22-24/25
WGK Germany  3
10

RELATED PRODUCTS